Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based medical training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; LAP Mentor simulator provides laparoscopic training; and LapSim essence, a portable and ready-to-use VR laparoscopic simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; GI Mentor, the gold standard simulator for the training of gastrointestinal upper and lower endoscopic procedures; Ultrasound Mentor, a cross-specialty solution for ultrasound training; Angio Mentor simulator provides endovascular training; Spine Mentor, a virtual reality training simulator for minimal invasive spine surgery; GI-BRONCH Mentor platform that offers a combined system for GI endoscopy and flexible bronchoscopy training; Perc Mentor simulator provides ultrasound and fluoroscopy training; ARTHRO Mentor, an advanced arthroscopic training simulator; PELVIC Mentor simulator provides anatomy and pelvic exam training; URO Mentor, a virtual reality simulator for endourology training; simbionix simulators; and robotic surgery simulators. Surgical Science AB was incorporated in 1997 and is headquartered in Gothenburg, Sweden.
Stock data | 2022 | Change |
---|---|---|
Price | $12.93 | N/A |
Market Cap | $656.61M | N/A |
Shares Outstanding | 50.80M | 19.57% |
Employees | 260.00 | N/A |
Shareholder Equity | 4.24B | 18.17% |
Valuation | 2022 | Change |
---|---|---|
P/E Ratio | 3.50 | N/A |
P/S Ratio | 8.77 | N/A |
P/B Ratio | 0.15 | N/A |
Growth | 2022 | Change |
---|---|---|
Return on Equity | 0.0041 | N/A |
Earnings | 2022 | Change |
---|---|---|
Revenue | $74.89M | N/A |
Earnings | $17.54M | N/A |
EPS | 3.69 | N/A |
Earnings Yield | 0.2855 | N/A |
Gross Margin | 0.6623 | N/A |
Operating Margin | 0.2025 | N/A |
Net income margin | 0.2342 | N/A |
Financial Strength | 2022 | Change |
---|---|---|
Total Assets | $433.91M | N/A |
Cash on Hand | $40.48M | N/A |
Debt to Equity | 0.0091 | -11.06% |
Current Ratio | $2.70 | 1.76% |